Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: OutcomeDefinition for End-stage kidney disease

Computable Name:

version: 71; Last updated: 2026-08-06 19:22:47+0000

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/EvidenceVariable/236965

identifier: FEvIR Object Identifier/236965, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313960, outcomeId/313960, picoId/85798, sectionId/73215

name: End_stage_kidney_disease313960

title: OutcomeDefinition for End-stage kidney disease

shortTitle: End-stage kidney disease

citeAs:

OutcomeDefinition for End-stage kidney disease [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236965. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236965. Computable resource at: https://fevir.net/resources/EvidenceVariable/236965#json.

status: Active

author: Computable Publishing®: MAGIC-to-FEvIR Converter:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

End-stage kidney disease

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

RelatesTos

-TypeTarget[x]
*Part OfMAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

Definitions

-Concept
*End-stage kidney disease

handling: dichotomous variable